PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 71 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,935 | -5.7% | 24,690 | +26.6% | 0.00% | -33.3% |
| Q2 2023 | $68,835 | -36.2% | 19,500 | -44.1% | 0.00% | -25.0% |
| Q1 2023 | $107,841 | -45.6% | 34,900 | -25.5% | 0.00% | -63.6% |
| Q4 2022 | $198,108 | +73.8% | 46,834 | +18.0% | 0.01% | +120.0% |
| Q1 2022 | $114,000 | -17.4% | 39,700 | -12.6% | 0.01% | -44.4% |
| Q4 2021 | $138,000 | -40.5% | 45,400 | +97.4% | 0.01% | -80.9% |
| Q3 2020 | $232,000 | – | 23,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |